These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16027403)

  • 1. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.
    Yu CY; Campbell SE; Zhu B; Knadler MP; Small DS; Sponseller CA; Hunt TL; Morgan RE
    Curr Med Res Opin; 2012 Feb; 28(2):187-94. PubMed ID: 22149769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
    Schneck DW; Birmingham BK; Zalikowski JA; Mitchell PD; Wang Y; Martin PD; Lasseter KC; Brown CD; Windass AS; Raza A
    Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.
    Jindal D; Tandon M; Sharma S; Pillai KK
    Eur J Clin Pharmacol; 2005 Oct; 61(9):621-5. PubMed ID: 16133549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
    Simonson SG; Raza A; Martin PD; Mitchell PD; Jarcho JA; Brown CD; Windass AS; Schneck DW
    Clin Pharmacol Ther; 2004 Aug; 76(2):167-77. PubMed ID: 15289793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fluconazole on the pharmacokinetics of rosuvastatin.
    Cooper KJ; Martin PD; Dane AL; Warwick MJ; Schneck DW; Cantarini MV
    Eur J Clin Pharmacol; 2002 Nov; 58(8):527-31. PubMed ID: 12451430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
    J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
    Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
    Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
    van der Lee M; Sankatsing R; Schippers E; Vogel M; Fätkenheuer G; van der Ven A; Kroon F; Rockstroh J; Wyen C; Bäumer A; de Groot E; Koopmans P; Stroes E; Reiss P; Burger D
    Antivir Ther; 2007; 12(7):1127-32. PubMed ID: 18018771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
    Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.
    Trabelsi F; Bartůnek A; Vlavonou R; Navrátilová L; Dubé C; Tanguay M; Hauser T
    Int J Clin Pharmacol Ther; 2012 Oct; 50(10):741-50. PubMed ID: 22762855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin-warfarin drug interaction.
    Barry M
    Lancet; 2004 Jan; 363(9405):328. PubMed ID: 14751711
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.
    Kostapanos MS; Milionis HJ; Saougos VG; Lagos KG; Kostara C; Bairaktari ET; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):292-7. PubMed ID: 18172223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
    Guerret M; Francheteau P; Hubert M
    Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.
    Martin PD; Warwick MJ; Dane AL; Cantarini MV
    Clin Ther; 2003 Aug; 25(8):2215-24. PubMed ID: 14512129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil.
    Bergman E; Lundahl A; Fridblom P; Hedeland M; Bondesson U; Knutson L; Lennernäs H
    Drug Metab Dispos; 2009 Dec; 37(12):2349-58. PubMed ID: 19773540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.